1. Information about this Guideline – Endometrial Cancer
1.1 Editors
German Guideline Program in Oncology (GGPO) of the Association of the Scientific Medical Societies in Germany (AWMF), the German Cancer Society (DKG), and the German Cancer Aid Foundation (DKH).
1.2 Leading Scientific Societies
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG)
Deutsche Krebsgesellschaft (DKG) vertreten durch die Arbeitsgemeinschaft Gynäkologische Onkologie (AGO)
1.3 Funding of the Guideline
This guideline was sponsored by the German Cancer Aid Foundation within the framework of the German Guideline Program in Oncology.
1.4 Contact
Office Leitlinienprogramm Onkologie
c/o Deutsche Krebsgesellschaft e. V.
Kuno-Fischer-Straße 8
14057 Berlin
leitlinienprogramm@krebsgesellschaft.de
www.leitlinienprogramm-onkologie.de
1.5 How to cite
Leitlinienprogramm-Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3 Guideline Endometrial Cancer, Langversion 2.0, 2022, AWMF-Registernummer 032/034-OL, https://www.leitlinienprogramm-onkologie.de/leitlinien/endometriumkarzinom/
1.6 Special Comment
Medicine is subject to a continuous development process, so that all information, in particular on diagnostic and therapeutic procedures, can correspond only to the state of knowledge at the time of printing of the guideline. The greatest possible care has been taken with regard to the recommendations given for therapy and the selection and dosage of medications. Nevertheless, users are urged to consult the manufacturers' package inserts and expert information for verification and, in case of doubt, to consult a specialist. In the general interest, any discrepancies should be reported to the OL editorial office.
The user remains responsible for any diagnostic and therapeutic application, medication and dosage.
In this Guideline, registered trademarks (protected trade names) are not specially marked. It can therefore not be concluded from the absence of a corresponding reference that it is a free trade name.
The work is protected by copyright in all its parts. Any use outside the provisions of copyright law without the written consent of the OL editorial office is prohibited and punishable by law. No part of the work may be reproduced in any form without the written permission of the OL editorial office. This applies in particular to reproductions, translations, microfilming and the storage, use and exploitation in electronic systems, intranets and the Internet.
1.7 Objectives of the GGPO
The Association of the Scientific Medical Societies in Germany (AWMF), the German Cancer Society (DKG) and the German Cancer Aid Foundation (Stiftung Deutsche Krebshilfe) have set themselves the goal of jointly promoting and supporting the development, updating and use of scientifically based and practicable guidelines in oncology with the Guideline Program in Oncology (OL). The basis of this program is based on the medical-scientific findings of the professional societies and the DKG, the consensus of medical experts, users and patients, as well as on the set of rules for guideline development of the AWMF and the professional support and funding by the German Cancer Aid. In order to reflect the current state of medical knowledge and to take medical progress into account, guidelines must be regularly reviewed and updated. The application of the AWMF regulations should be the basis for the development of high quality oncological guidelines. Since guidelines are an important instrument of quality assurance and quality management in oncology, they should be introduced into everyday care in a targeted and sustainable manner. Thus, active implementation measures and also evaluation programs are an important part of the promotion of the German Guideline Program in Oncology. The aim of the program is to create professional and medium-term financially secure conditions for the development and provision of high-quality guidelines in Germany. This is because these high-quality guidelines not only serve the structured transfer of knowledge but can also find their place in shaping the structures of the healthcare system. Mention should be made here of evidence-based guidelines as a basis for creating and updating disease management programs or the use of quality indicators extracted from guidelines as part of the certification of organ tumor centers.
1.8 Additional Documents relating to this Guideline
In addition to the present long version of the Level 3 guideline on endometrial cancer, the following supplementary documents on the guideline are also available:
- Guideline report on updating the guideline
- Document with evidence tables for the guideline
- Short version of the guideline
- Patient guideline
- English translation
All guideline documents are available from the following web sites:
- Guideline Program Oncology (https://www.leitlinienprogramm-onkologie.de/leitlinien/endometriumkarzinom/)
- AWMF (http://www.awmf.org/leitlinien/aktuelle-leitlinien.html)
- Guidelines International Network (www.g-i-n.net)
Documents on previous versions of the guideline are available in the guideline archive:
https://www.leitlinienprogramm-onkologie.de/leitlinien/endometriumkarzinom/.
This guideline is also included in the Guideline Program Oncology app.
For more information, visit: https://www.leitlinienprogramm-onkologie.de/app/
1.9 Composition of the Guideline Group
1.9.1 Coordination and Reaction
The Guideline is published by the German Guideline Program in Oncology (GGPO) of the German Cancer Society (DKG). The lead professional society is the German Society of Gynecology and Obstetrics (DGGG). The Guideline is part of the German Guideline Program in Oncology (GGPO) supported by the German Cancer Society (DKG) together with the German Cancer Aid (DKH) and the AWMF. The coordinator was appointed by the lead society (DGGG). He determined the composition and distribution of tasks of the Guideline steering group as follows:
Coordinator: Prof. Dr. Günter Emons; Göttingen
Co-coordinator: Prof. Dr. Eric Steiner; Rüsselsheim
Editors: Saskia Erdogan, M.A.; Göttingen, Sylvia Weber; Göttingen
The tasks of the steering group included contact and feedback with the participating professional societies and organizations, implementing the methodological guidelines, preparation of a project plan, management of the financial resources, support of the content-related work of the experts, compilation and editing of the texts prepared by the experts and working groups, and documentation of a Guideline report.
Steering group
Prof. Dr. Günter Emons; Göttingen
Prof. Dr. Eric Steiner; Rüsselsheim
Kerstin Paradies; Hamburg
Dr. Christoph Uleer; Hildesheim
Prof. Dr. Dirk Vordermark; Halle/Saale
1.9.2 Other Patient Involvement (without voting rights)
1.9.3 Patient Involvement
The representatives of the patient organizations Frauenselbsthilfe Krebs e. V., Heidemarie Haase and Miriam Schallenberg, and Semi Colon, Simone Widhalm and Nicola Reents were involved in the consensuses during the preparation of the Guideline.
1.9.4 Methodological Support
By the Guideline Program Oncology and the Association of the Scientific Medical Societies e.V.:
- Dr. Monika Nothacker, MPH (AWMF Institute for Medical Knowledge Management (AWMF-IMWi).
- Dr. Susanne Blödt, MScPH (AWMF Institute for Medical Knowledge Management (AWMF-IMWi)
- Dr. Markus Follmann, MPH, MSc, Office of the Guideline Program Oncology c/o DKG
- Dipl.-Soz.Wiss Thomas Langer, Office of the Guideline Program Oncology c/o DKG
- Dipl. Biologe Gregor Wenzel, Office of the Guideline Program Oncology c/o DKG
By external contractors:
- Dr. Paul Freudenberger (Berlin) and Dr. Nadine Steubesand (Kiel) User Group of Clinical Guideline Services GmbH; in the systematic literature research and subsequent evidence assessment, including preparation of the evidence tables for the methods report
- PD Dr. Simone Wesselmann, MBA; German Cancer Society - Certification Division (coordination in the preparation of the quality indicators)